Holen Sie sich die Stockscreener-App
28.67
2.32%
0.65
Handel nachbörslich:
28.67
Cg Oncology Inc Aktie (CGON) Neueste Nachrichten
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 2,503 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology (NASDAQ:CGON) Shares Down 4.3%Time to Sell? - MarketBeat
CG Oncology Enters Oversold Territory (CGON) - Nasdaq
State Street Corp Raises Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
State Street Corp Acquires 717,722 Shares of CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Cg oncology director Leonard Post sells $28,840 in stock By Investing.com - Investing.com Australia
Franklin Resources Inc. Has $46.16 Million Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Cg oncology director Song Hong Fang sells shares worth $19.6 million - Investing.com India
Hong Fang Song Sells 700,000 Shares of CG Oncology, Inc. (NASDAQ:CGON) Stock - MarketBeat
Cg oncology director Leonard Post sells $28,840 in stock - Investing.com
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares - Marketscreener.com
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Marketscreener.com
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - The Manila Times
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase - EIN News
CG Oncology's SWOT analysis: cretostimogene's potential reshapes NMIBC stock outlook - Investing.com
CG Oncology's SWOT analysis: cretostimogene's potential reshapes NMIBC stock outlook By Investing.com - Investing.com South Africa
Jane Street Group LLC Buys 138,400 Shares of CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Latham & Watkins Advises on CG Oncology’s Public Offering - Legal Desire News Network
CG Oncology (NASDAQ:CGON) Sees Large Volume IncreaseWhat's Next? - MarketBeat
Wellington Management Group LLP Acquires 308,852 Shares of CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
CG Oncology (NASDAQ:CGON) vs. LENZ Therapeutics (NASDAQ:LENZ) Head-To-Head Survey - Defense World
CG Oncology (NASDAQ:CGON) versus Fresh Tracks Therapeutics (NASDAQ:FRTX) Head-To-Head Comparison - Defense World
Cg Oncology Inc (NASDAQ: CGON) Has Great Upside Potential - Stocks Register
CG Oncology: Positive Phase 3 Outcome Could Lead To BLA Of Cretostimogene (NASDAQ:CGON) - Seeking Alpha
Fmr LLC Raises Stock Position in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
CG Oncology Launches Major $204M IPO with Shares Priced at $28, Backed by Top Wall Street Banks - StockTitan
CG Oncology Announces Pricing of Public Offering - Marketscreener.com
CG Oncology Announces Pricing of Public Offering - GlobeNewswire Inc.
CG Oncology announces 7.3M share offering - MSN
Neo Ivy Capital Management Takes Position in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Why CG Oncology (CGON) Stock Is Down 9% - Benzinga
CGONCG Oncology, Inc. Latest Stock News & Market Updates - StockTitan
CG Oncology announces offering of 8M shares of common stock - TipRanks
CG Oncology Announces Proposed Public Offering - The Manila Times
Costco Wholesale (COST-Q) QuotePress Release - The Globe and Mail
CG Oncology Launches Major 8M Share Public Offering, Backed by Top Wall Street Banks - StockTitan
CG Oncology files to sell 8M shares of common stock - TipRanks
CG Oncology, Inc. (NASDAQ:CGON) Position Boosted by BNP Paribas Financial Markets - MarketBeat
SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer Research Fellowship Award - Marketscreener.com
CG Oncology’s (CGON) “Outperform” Rating Reiterated at Royal Bank of Canada - Defense World
Charles Schwab Investment Management Inc. Purchases 202,262 Shares of CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
CG Oncology, Inc. (NASDAQ:CGON) Director Leonard E. Post Sells 1,000 Shares - MarketBeat
Royal Bank of Canada Reaffirms Outperform Rating for CG Oncology (NASDAQ:CGON) - MarketBeat
HC Wainwright Reaffirms Buy Rating for CG Oncology (NASDAQ:CGON) - MarketBeat
Cg oncology director Leonard Post sells shares worth $34,541 By Investing.com - Investing.com Nigeria
Cg oncology director Leonard Post sells shares worth $34,541 - Investing.com
Health Rounds: Experimental CG Oncology immunotherapy shows promise in bladder cancer - Reuters.com
CG Oncology keeps stock target with buy rating, impresses with Phase 3 results - Investing.com
Cg Oncology Inc’s (CGON) -6.54% Drop Is A Reason To Reconsider. - Stocks Register
SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award - The Manila Times
CG Oncology Launches Groundbreaking Research Fellowship for Bladder Cancer Innovation - StockTitan
Protara, CG Oncology Tout Promising Bladder Cancer Outcomes - BioSpace
CG Oncology announces data from Phase 3 BOND-003 trial - Yahoo Finance
Demystifying CG Oncology: Insights From 7 Analyst Reviews - Benzinga
Polar Asset Management Partners Inc. Makes New $973,000 Investment in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Point72 Asset Management L.P. Boosts Stake in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Janus Henderson Group PLC Boosts Stake in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
CG Oncology, Inc. Announces Topline Data from the Phase 3 Bond-003 Trial in Patients with High-Risk Non-Muscle Invasive Bladder Cancer - Marketscreener.com
CG Oncology Is Building A Best-In-Class Profile In NMIBC - News & Insights
CG Oncology Touts Encouraging Data From Late-Stage Study Of Bladder Cancer Candidate - AOL
CG Oncology's oncolytic virus shows durability in bladder cancer study - FirstWord Pharma
Protara, CG climb bladder ladder with SUO cancer findings - BioWorld Online
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):